We employ a three-step methodology that includes primary analysis, field assessment, and execution to help companies develop actionable and customized projects and plans, formulate solutions to market access challenges, and facilitate successful commercialization throughout Europe and the Middle East.
Analyze the relevant clinical and economic evidence per the health authorities expectations and review the literature and guidelines.
Assess the position of a new device or therapy in current clinical practice versus the gold standard.
Analyze the current coding and payment in the national and regional databases per country.
Provide a roadmap for market access and reimbursement and a comprehensive action plan for implementing the relevant strategies within their respective timelines.
Prepare a core value dossier or proposal for innovative health technologies to optimize assessment processes
Plan and participate in interviews with healthcare practitioners, hospital executives, and patient advocacy groups.
Prepare and participate in early dialogues with local policymakers and health technology evaluation agencies.
Advise and organize advisory board meetings with key opinion leaders and experts from different therapeutic areas.
Define the optimal pricing strategy and the required operational actions with payers.
Prepare reimbursement applications to secure coverage for innovative medical technologies.
Advise and develop a health economic model to generate evidence of the value of new interventions for reimbursement agencies and local healthcare payers.
Submit applications for CED programs (coverage with evidence development) for early authorization programs for innovative devices.